Glucose-dependent insulinotropic polypeptide directly induces glucose transport in rat skeletal muscle
However, this difference was not deemed statistically significant enough to confirm a direct causal relationship
Based on the estimated 3.8 million Part D enrollees eligible for the Medicare GLP-1 Bridge as of 2023, if 10% to 25% participate in Bridge from when the program launches in July 2026 and fill a prescription each month for the 18-month duration of the program, the cost to Medicare would be $1.3 billion to $3.3 billion (at a net monthly cost of $245 minus the $50 beneficiary copay)
Over the past few years, GLP-1 receptor agonistsincluding Ozempic (semaglutide) and Mounjaro (tirzepatide)have been prohibitively expensive for many people without generous insurance coverage
They work by stimulating insulin production, slowing down digestion, and promoting feelings of fullness, all of which contribute to healthy blood sugar levels
This website does not provide medical advice.These statements have not been evaluated by the Food and Drug Administration